Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|278|5|494-506

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.278, Iss.5, 2015-11, pp. : 494-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein‐Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 3, 2015-03 ,pp. : 442-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Etiopathogenesis of Systemic Lupus Erythematosus

By  

International Archives of Allergy and Immunology, Vol. 123, Iss. 1, 2000-09 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 3, 2015-03 ,pp. : 294-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Identification of a Pathogenic Variant in TREX1 in Early‐Onset Cerebral Systemic Lupus Erythematosus by Whole‐Exome Sequencing

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3382-3386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologicals for the treatment of systemic lupus erythematosus?

By Gunnarsson Iva   van Vollenhoven Ronald F.  

Annals of Medicine, Vol. 44, Iss. 3, 2012-05 ,pp. : 225-232

Informa Healthcare

Access to resources Recommend Favorite